All In Biotech

Drug Trial Radar · NCT06616766

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, PK and Anti-tumor Activity of YH42946 in Patients With Locally Advanced or Metastatic Solid Tumors With HER2 Aberration and EGFR Exon 20 Insertion

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

201

Planned (sponsor's estimate)

Start

Oct 2, 2024

Primary completion

Mar 15, 2028

Study completion Jul 29, 2028

Sponsor

Lead sponsor
Yuhan CorporationIndustry
Sponsor type
Industry
First posted
Sep 27, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this YH42946-101 is to evaluate the safety, Tolerability, Pharmacokinetics and anti-tumor activity of YH42946 in patients with locally advanced of metastatic solid tumors with HER2 aberration and EGFR exon 20 insertions.

Conditions

  • NSCLC (Non-small Cell Lung Cancer)
  • Solid Tumor

Interventions

  • YH42946Drug

    YH42946

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment Emergent Adverse Events(TEAE)sTime frame: Through study completion, during the first 21 days of DLT evaluation period.
  2. Objective Response Rate (ORR)Time frame: Through dose expansion part completion, approximately 12 months

Locations

8 sites in 2 countries. Site status is shown where the registry gives one.

  • Next Oncology Virginia

    Fairfax, Virginia · Terminated

  • Seoul National University Hospital

    Seoul, South Korea · Recruiting

  • Severance Hospital, Yonsei University

    Seoul, South Korea · Recruiting

  • Samsung Medical Center

    Seoul, South Korea · Recruiting

  • Asan Medical Center, University of Ulsan

    Seoul, South Korea · Recruiting

  • Seoul National University Bundang Hospital

    Seongnam-si, Gyeonggi-do, South Korea · Recruiting

  • The Catholic Univ. of Korea St. Vincent's Hospital

    Suwon, Gyeonggi-do, South Korea · Recruiting

  • Chungbuk National University Hospital

    Cheongju-si, North Chungcheong, South Korea · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.